Point72 Middle East FZE’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-244
Closed -$15.3K 232
2023
Q4
$15.3K Buy
+244
New +$15.3K ﹤0.01% 827